Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by BudFoxx2020on Nov 06, 2023 12:53pm
192 Views
Post# 35719680

RE:RE:RE:RE:Excellent News

RE:RE:RE:RE:Excellent News

Lol @ trusted voice.   There is a whole news release out today.  Just put in a little time to do some research and due dilligence.  Cheers.  

 

https://stockhouse.com/opinion/interviews/2023/11/06/theralase-raising-up-to-5-3m-to-complete-bladder-cancer-study
 

Over the next six months the company is working on a pre-breakthrough designation approval for the FDA and will focus on enrolling and treating and additional 37 patients in the clinical study.

N0taP00p wrote: Eoganacht: You're one of the trusted voices here.  Did you mean pre-BTD submission or BTD submission by year end?  I'm not surprised if they pushed again without explicitly saying so. It's all moot if they can't raise money. 
Eoganacht wrote: The great news is that Theralase has confirmed they will submit the BTD application before year end, they are now plainly stating that Ruvidar PDT is better than both FDA approved treatments Keytruda and Adstiladrin, and they treated one more patient. Just 37 patients to go.

Legit62 wrote: whats the great news Knoxt?? were they able to fill it??





 

<< Previous
Bullboard Posts
Next >>